Jump to content

Additional Treatment Pathway for COVID Outpatients Starting March 1


webfact

Recommended Posts

e2fb4a949ef9ac591d182e291a534bfa_small.jpg

 

by Natthaphon  Sangpolsit

    

BANGKOK (NNT) - The Ministry of Public Health is now aiming to re-categorize COVID-19 as an endemic disease within four months, saying the transition will be facilitated by a “detect, dispense, conclude” protocol that will soon be implemented for outpatients.

 

Dr Kiattiphum Wongrajit, permanent secretary for the Ministry of Public Health, explained that under the “detect, dispense, conclude” service, suspected cases will be tested using antigen test kits (ATKs). A positive result will prompt a doctor to dispense medication under three formulas. The first formula employs Favipiravir drugs while the second involves green chiretta. The third formula dispenses treatments for cough, fever or runny nose according to a patients’ symptoms.

 

The new service is expected to facilitate the transition of COVID into a disease that can be self-managed without hospitalization. The new protocol will be provided as an alternative choice for treatment alongside existing channels.

 

“Detect, dispense, conclude” will be implemented on March 1.

 

Kiatiphum said the provinces of Chiang Mai and Phuket have already implemented this treatment protocol with favorable results. Implementation has also been ongoing at various healthcare facilities, such as Siriraj Hospital in Bangkok.

 

The permanent secretary said the protocol enables patients to avoid close contact with others and reduce travel requirements. Certain patients within the “608” group of individuals at high risk of severe symptoms may also opt for this treatment pathway.

 

nnt.jpg
-- © Copyright NNT 2022-02-28
 

- Aetna offers a range of visa-compliant plans that meet the minimum requirement of medical treatment, including COVID-19, up to THB 3m. For more information on all expat health insurance plans click here.

 

Link to comment
Share on other sites

4 hours ago, webfact said:

The first formula employs Favipiravir drugs while the second involves green chiretta.

Few other countries seem to be using Favipiravir against Covid due to its questionable (or unquestionably limited) efficacy, and I won't even comment on "green chiretta".

 

It could be argued that those who can be helped with those "medicines" would have been fine with just paracetamol and plenty of fluids, which is the "formula" elsewhere for mild cases.

  • Like 2
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.








×
×
  • Create New...
""